CYTO
Altamira Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · BM
$0.30
+0.00%Latest reported
- Last report date
- Sep 24, 2024
- EPS actual
- -$1.99
- EPS estimate
- -$2.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -369.4%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 16, 2025